Skip to content

13F-HR filed by Avidity Partners Management LP

Avidity Partners Management LP filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 68 holding rows worth $2,155,960,000.

Accession
0001791827-20-000006
Filed
2020-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2020

A holdings report, 68 entries on the cover page, a total value of $2,155,960,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,155,960,000 with VALUE read as thousands by filing date, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PFIZER INC717081903CALL6,500,000$238,550,000thousands by filing datecall
AbbVie,Inc.00287Y109COM1,522,800$133,382,000thousands by filing date
SEATTLE GENETICS INC812578102COM531,100$103,931,000thousands by filing date
AVANTOR INC COM05352A100Stock4,562,400$102,608,000thousands by filing date
Merck & Co.,Inc.58933Y105COM1,144,300$94,920,000thousands by filing date
BIOGEN INC COM09062X103Stock315,100$89,388,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM1,284,200$83,486,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS930,200$72,258,000thousands by filing date
NOVABRIDGE BIOSCIENCES44975P103CMN1,340,000$63,020,000thousands by filing date
BIOGEN INC09062X903CALL214,100$60,736,000thousands by filing datecall
AURINIA PHARMACEUTICALS INC COM05156V102Stock3,564,900$52,511,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM118,300$52,232,000thousands by filing date
BRISTOL-MYERS SQUIBB CO110122157RIGHT 99/99/999922,684,932$51,041,000thousands by filing date
BAXTER INTL INC071813109COM620,000$49,860,000thousands by filing date
Elevance Health, Inc.036752103COM176,400$47,379,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock402,000$46,025,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM275,000$45,664,000thousands by filing date
QUIDEL CORP74838J101COM176,879$38,804,000thousands by filing date
Boston Scientific Corporation101137107COM967,100$36,953,000thousands by filing date
CHANGE HEALTHCARE INC15912K100COM2,527,500$36,674,000thousands by filing date
NATERA INC COM632307104Stock503,400$36,366,000thousands by filing date
KADMON HLDGS INC48283N106COM9,030,000$35,398,000thousands by filing date
ARVINAS INC04335A105COM1,348,300$31,833,000thousands by filing date
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK904,119$29,556,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM1,854,100$27,367,000thousands by filing date
CATALENT INC USD 0.01148806102COM318,100$27,248,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM799,000$26,303,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock1,746,000$24,811,000thousands by filing date
BIOXCEL THERAPEUTICS INC09075P105COM538,000$23,328,000thousands by filing date
HUMANA INC COM444859102Stock51,500$21,315,000thousands by filing date
ANIKA THERAPEUTICS INC035255108COM601,700$21,294,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM1,000,400$20,828,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM1,171,700$19,907,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW4,506,000$18,970,000thousands by filing date
ATHIRA PHARMA INC04746L104COM1,026,342$18,946,000thousands by filing date
Medtronic PlcG5960L103COM181,000$18,810,000thousands by filing date
EXELIXIS INC COM30161Q104Stock769,200$18,807,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM623,300$18,805,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK7,324,000$18,383,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR2,084,700$16,636,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW2,087,800$14,406,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR206,000$14,261,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock757,400$14,103,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock1,050,800$13,198,000thousands by filing date
ZYMEWORKS INC98985W102COM244,700$11,398,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM1,430,000$10,596,000thousands by filing date
TAYSHA GENE THERAPIES INC877619106COMMON STOCK392,000$8,781,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW2,025,000$8,748,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock118,000$8,408,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM330,000$8,141,000thousands by filing date
AC IMMUNE SAH00263105SHS1,550,000$7,564,000thousands by filing date
ALPINE IMMUNE SCIENCES INC02083G100COM810,000$7,120,000thousands by filing date
VESPER HEALTHCARE ACQSTN COR92538T203UNIT 99/99/9999600,000$6,156,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM1,000,000$5,830,000thousands by filing date
ARYA SCIENCES ACQUISTION COG31655114UNIT 06/09/2027500,000$5,408,000thousands by filing date
OAK STR HEALTH INC67181A107COM100,000$5,344,000thousands by filing date
PMV PHARMACEUTICALS INC69353Y103COM150,000$5,325,000thousands by filing date
OUTSET MEDICAL INC690145107COM100,000$5,000,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS400,000$4,400,000thousands by filing date
PANACEA ACQUISITION CORP698102209UNIT 99/99/9999300,000$3,600,000thousands by filing date
BCTG ACQUISITION CORP05492W103COM300,000$3,108,000thousands by filing date
BERKELEY LTS INC084310101COM25,000$1,909,000thousands by filing date
NURIX THERAPEUTICS INC67080M103COMMON STOCK50,000$1,746,000thousands by filing date
INOZYME PHARMA INC45790W108COM61,855$1,626,000thousands by filing date
ACCOLADE INC00437E102COM40,000$1,555,000thousands by filing date
AMERICAN WELL CORP03044L105CL A50,000$1,482,000thousands by filing date
RELAY THERAPEUTICS INC COM75943R102Stock30,000$1,278,000thousands by filing date
ANNEXON INC03589W102COM37,570$1,136,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001791827-20-000006this filing2020-11-16acceptance time not in the bulk data set